Dunkern; Torsten
Patent Applications and Registrations
Patent applications and USPTO patent grants for Dunkern; Torsten.The latest application filed is for "6-membered cyclic amines or lactames substituted with urea and phenyl".
- Dunkern; Torsten - Juchen DE
- Dunkern; Torsten - Juechen Gierath DE
- DUNKERN; Torsten - Junchen Gierath DE
- Dunkern; Torsten - Juchen Gierath N/A DE
- Dunkern; Torsten - Volkertshausen N/A DE
- Dunkern; Torsten - Stockach DE
| Patent | Date |
|---|---|
| 6-membered cyclic amines or lactames substituted with urea and phenyl Grant 10,265,310 - Jakob , et al. | 2019-04-23 |
| 6-membered Cyclic Amines Or Lactames Substituted With Urea And Phenyl App 20180078541 - JAKOB; FLORIAN ; et al. | 2018-03-22 |
| Methylpyrrolopyrimidinecarboxamides Grant 9,376,442 - Stadlwieser , et al. June 28, 2 | 2016-06-28 |
| Novel Phthalazinone-Pyrrolopyrimidinecarboxamide Derivatives App 20160108049 - STENGEL; Thomas ; et al. | 2016-04-21 |
| EP2 receptor agonists Grant 9,309,187 - Hoffmeyer , et al. April 12, 2 | 2016-04-12 |
| 3,4,4a,10b-Tetrahydro-1H-thiopyrano-[44,3-c] isoquinoline derivatives Grant 9,018,175 - Flockerzi , et al. April 28, 2 | 2015-04-28 |
| Novel EP2 Receptor Agonists App 20150080400 - Hoffmeyer; Angelika ; et al. | 2015-03-19 |
| Methylpyrrolopyrimidinecarboxamides App 20150073001 - STADLWIESER; Josef ; et al. | 2015-03-12 |
| Methylpyrrolopyrimidinecarboxamides Grant 8,927,557 - Stadlwieser , et al. January 6, 2 | 2015-01-06 |
| Methylpyrrolopyridinecarboxamides Grant 8,816,085 - Stadlwieser , et al. August 26, 2 | 2014-08-26 |
| Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c] Isoquinoline Compounds App 20140113877 - Flockerzi; Dieter ; et al. | 2014-04-24 |
| Novel Phthalazinone-pyrrolopyrimidinecarboxamide Derivatives App 20140112945 - Stengel; Thomas ; et al. | 2014-04-24 |
| Substituted 7-carboxamido-pyrrolo[3,2-d]pyrimidines Grant 8,445,501 - Stadlwieser , et al. May 21, 2 | 2013-05-21 |
| 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES App 20120289474 - Flockerzi; Dieter ; et al. | 2012-11-15 |
| Use for PDE5 inhibitors Grant 8,278,300 - Dunkern , et al. October 2, 2 | 2012-10-02 |
| Composition Comprising A Pde4 Inhibitor And A Pde5 Inhibitor App 20120196867 - DUNKERN; Torsten ; et al. | 2012-08-02 |
| Methylpyrrolopyrimidinecarboxamides App 20120149721 - Stadlwieser; Josef ; et al. | 2012-06-14 |
| Methylpyrrolopyridinecarboxamides App 20120142633 - Stadlwieser; Josef ; et al. | 2012-06-07 |
| Pyrrolopyrimidinecarboxamides App 20110021479 - Stadlwieser; Josef ; et al. | 2011-01-27 |
| Composition Comprising A Pde4 Inhibitor And A Pde5 Inhibitor App 20100234382 - DUNKERN; Torsten ; et al. | 2010-09-16 |
| Novel use for PDE5 inhibitors App 20100179152 - Dunkern; Torsten ; et al. | 2010-07-15 |
| 6-benzyl-2,3,4,7-tetrahydro-indolo [2,3-c] Quinoline Compounds Useful As Pde5 Inhibitors App 20100120730 - Weinbrenner; Steffen ; et al. | 2010-05-13 |
| Use for PDE5 inhibitors Grant 7,666,872 - Dunkern , et al. February 23, 2 | 2010-02-23 |
| Use of Pde1c and Inhibitors Thereof App 20090030065 - Dunkern; Torsten ; et al. | 2009-01-29 |
| Novel use for pde5 inhibitors App 20070185114 - Dunkern; Torsten ; et al. | 2007-08-09 |
| Composition comprising a pde4 inhibitor and a pde5 inhibitor App 20060094723 - Dunkern; Torsten ; et al. | 2006-05-04 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 